Acadia Healthcare Breaking New Ground in South Carolina with Recent Acquisitions

Acadia Healthcare (NASDAQ: ACHC) has announced its acquisition of three opioid treatment clinics in South Carolina, a move that expands the company’s already extensive network of Comprehensive Treatment Centers (CTCs). These newly rebranded facilities—Clinton Comprehensive Treatment Center, Easley Comprehensive Treatment Center, and Ridgeland Comprehensive Treatment Center—are part of Acadia Healthcare’s broader strategy to address the rising demand for opioid treatment services across the United States.

Expanding Access to Opioid Treatment

Acadia Healthcare is the largest stand-alone behavioral health company in the U.S., with 258 facilities spread across 38 states and Puerto Rico. The acquisition of these three South Carolina clinics represents a significant step toward increasing access to opioid use disorder treatment in underserved regions. As part of Acadia’s CTC division, these facilities will offer medication-assisted treatment (MAT) combined with counseling and other therapeutic services to help individuals struggling with opioid addiction.

Medication-assisted treatment, a cornerstone of Acadia’s addiction care model, includes FDA-approved medications like methadone and buprenorphine. These treatments are used alongside behavioral therapies to address both the physical and mental aspects of addiction. The new South Carolina clinics will provide individualized treatment plans, ensuring patients receive the appropriate medical and psychological support as they work toward recovery.

Acadia Healthcare’s Role in Addressing the Opioid Crisis

The opioid epidemic continues to take a toll on communities across the U.S., and South Carolina is no exception. With opioid overdose deaths reaching alarming levels in recent years, the need for accessible, evidence-based treatment options is more critical than ever. Acadia Healthcare’s acquisition of these clinics is part of the company’s broader commitment to addressing this crisis.

Each newly acquired clinic will offer a range of services, including individual and group counseling, medical support, and vocational assistance to help patients rebuild their lives. Acadia’s focus on comprehensive care means that patients not only receive medical treatment for opioid addiction but also the counseling and life skills support necessary for long-term success.

Growth Strategy and Long-Term Plans

Acadia Healthcare’s acquisition of the South Carolina clinics follows a similar move earlier this year in North Carolina, where the company also expanded its opioid treatment offerings. This regional expansion reflects Acadia’s long-term strategy to increase its presence in the southeastern U.S., a region where opioid addiction rates are among the highest in the country. The company’s CTC division now operates 165 locations across 33 states, serving over 72,000 patients daily.

NASDAQ: ACHC has been clear about its growth strategy, which includes mergers and acquisitions, new clinic openings, and partnerships with local health systems. The addition of the South Carolina clinics not only strengthens Acadia’s existing network but also positions the company to continue expanding into new markets. With plans to open 14 additional CTCs nationwide by the end of 2024, Acadia Healthcare remains focused on meeting the growing demand for opioid treatment services across the country.

Acadia Healthcare’s role as a key player in the behavioral health industry has only grown in recent years. As the opioid crisis continues to evolve, the company’s commitment to providing high-quality, comprehensive care ensures that individuals in need of treatment will have access to the services they require to begin their recovery journey.

Comments are closed.